Boston Scientific receives safety approval for deep brain stimulation product

News

Author: Parkinson's Life editorsPublished: 22 December 2017

Prep: Cook: Serves:

Medical manufacturer Boston Scientific has received approval from the U.S. Food and Drug Administration for the Vercise Deep Brain Stimulation System, a device engineered to customise therapy for people living with Parkinson’s.

The approval was based on the INTREPID study, a test that evaluated the safety and effectiveness of the system on 292 people with Parkinson’s.

The first commercial implant is scheduled to take place at the University of Minnesota Medical Center, US, by a team of faculty professionals.

Dr Jerrold Vitek, professor of neurology at the University of Minnesota, said: “The Vercise Deep Brain Stimulation System changes the landscape of what physicians can do to help improve the quality of life for people living with Parkinson’s disease.

“This system provides an ability to sculpt the current field in the deep brain stimulation target using novel technology that offers flexibility in programming.”

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

“Speaking provides me with purpose and meaning”

A lawyer turned inspirational speaker on living with Parkinson’s disease

Parkinson’s disease and loneliness: “people are hungry for some connection”

Dr Indu Subramanian on the how and why of staying socially connected

Five years of Parkinson’s campaigning

Parkinson’s Life sends its 250th newsletter

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

Could a specialised smartwatch support people with Parkinson’s disease?

A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Boston Scientific receives safety approval for deep brain stimulation product

News

Author: Parkinson's Life editorsPublished: 22 December 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

“Speaking provides me with purpose and meaning”

Special reports

Parkinson’s disease and loneliness: “people are hungry for some connection”

Global update

Five years of Parkinson’s campaigning

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

Boston Scientific receives safety approval for deep brain stimulation product

News

Author: Parkinson's Life editorsPublished: 22 December 2017

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

“Speaking provides me with purpose and meaning”

Special reports

Parkinson’s disease and loneliness: “people are hungry for some connection”

Global update

Five years of Parkinson’s campaigning

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

Sign in